Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Oncol. Jan 24, 2020; 11(1): 11-19
Published online Jan 24, 2020. doi: 10.5306/wjco.v11.i1.11
Table 1 Demographics and clinical information, n (%)
CharacteristicPatients with lung metastases (n = 6)Patients without lung metastases (n = 49)P value
Age at diagnosis (yr)57.840.20.064
Gender
Male5 (83.3)21 (42.9)
Female1 (16.7)28 (57.1)
Parotidectomy type0.00013
Superficial1 (16.7)39 (79.5)
Total5 (83.3)10 (20.4)
Neck dissection3 (50.0)7 (14.3)0.08
Positive margins1 (16.7)6 (12.2)0.77
Gross nerve invasion6 (100)0< 0.0001
Greatest dimension5.20 cm2.58 cm< 0.0001
Initial overall stage
I021 (42.8)
II019 (38.7)
III006 (12.2)
IV6 (100)2 (4.1)
Unknown
Initial T-stage
T1024 (48.9)
T2018 (36.7)
T306 (12.2)
T46 (100)1 (2.0)
Tx00
Initial nodal status
N05 (83.3)47 (95.9)
N101 (2.0)
N21 (16.7)1 (2.0)
N300
Nx00
High-grade3 (50)1 (2.0)0.019
Adjuvant XRT5 (83.3)14 (28.6)< 0.001
Table 2 Characteristics of patients with lung metastases
Patient characteristicsGradeT-classificationFacial nerve invasionRecurrence sites
63 yr MaleHighT4aYesLocal, distant (lungs)
77 yr FemaleLowT4aYesDistant (lungs)
44 yr MaleHighT4aYesDistant (lungs)
52 yr MaleHighT4aYesDistant (lungs)
71 yr MaleLowT4aYesRegional, distant (lungs)
40 yr MaleLowT4aYesLocal, regional, distant (lungs)